Teva Pharmaceutical Industries Limited is a global pharmaceutical company engaged in development, production, marketing and distribution of products in two operating segments, Pharmaceuticals and Active Pharmaceutical Ingredients. The Pharmaceutical segment develops, produces, markets and distributes medicines in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Teva has utilized its production and research capabilities to establish a global pharmaceutical operation focused on supplying the growing demand for generic drugs and on the opportunities for proprietary branded products for specific niche categories, with its branded drug being Copaxone for multiple sclerosis. The Active Pharmaceutical Ingredients (API) segment develops, produces, markets and distributes API for the pharmaceutical industry, including the Company's pharmaceutical segment.